Michael G. Brattain
Affiliations: | Microbiology and Immunology | State University of New York, Buffalo, Buffalo, NY, United States |
Area:
Molecular BiologyGoogle:
"Michael Brattain"Children
Sign in to add trainee| Li-Wu Guo | grad student | 2004 | SUNY Buffalo |
| Dong-Weon Song | grad student | 2005 | SUNY Buffalo |
| Yunfei Zhou | grad student | 2005 | SUNY Buffalo |
| Ruiwen Wang | grad student | 2007 | SUNY Buffalo |
| Neka Simms | grad student | 2009 | SUNY Buffalo |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Ammanamanchi S, Tillekeratne MPM, Ko TC, et al. (2019) Retraction: Endogenous Control of Cell Cycle Progression by Autocrine Transforming Growth Factor β in Breast Cancer Cells. Cancer Research. 79: 1016 |
| Leiphrakpam PD, Brattain MG, Black JD, et al. (2018) TGFβ and IGF1R signaling activate protein kinase A through differential regulation of ezrin phosphorylation in colon cancer cells. The Journal of Biological Chemistry |
| Robb CM, Kour S, Contreras JI, et al. (2018) Characterization of CDK(5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapy. Oncotarget. 9: 5216-5232 |
| Bailey KL, Agarwal E, Chowdhury S, et al. (2017) TGFβ/Smad3 regulates proliferation and apoptosis through IRS-1 inhibition in colon cancer cells. Plos One. 12: e0176096 |
| Agarwal E, Robb CM, Smith LM, et al. (2017) Role of Akt2 in regulation of metastasis suppressor 1 expression and colorectal cancer metastasis. Oncogene |
| Fisher KW, Das B, Kim HS, et al. (2015) AMPK promotes aberrant PGC1β expression to support human colon tumor cell survival. Molecular and Cellular Biology |
| Agarwal E, Chaudhuri A, Leiphrakpam PD, et al. (2014) Akt inhibitor MK-2206 promotes anti-tumor activity and cell death by modulation of AIF and Ezrin in colorectal cancer. Bmc Cancer. 14: 145 |
| Leiphrakpam PD, Agarwal E, Mathiesen M, et al. (2014) In vivo analysis of insulin-like growth factor type 1 receptor humanized monoclonal antibody MK-0646 and small molecule kinase inhibitor OSI-906 in colorectal cancer. Oncology Reports. 31: 87-94 |
| Hedrick ED, Agarwal E, Leiphrakpam PD, et al. (2013) Differential PKA activation and AKAP association determines cell fate in cancer cells. Journal of Molecular Signaling. 8: 10 |
| Zou Y, Howell GM, Humphrey LE, et al. (2013) Ron knockdown and Ron monoclonal antibody IMC-RON8 sensitize pancreatic cancer to histone deacetylase inhibitors (HDACi). Plos One. 8: e69992 |